Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE)
Sponsor: AFM-Téléthon (Funding)
Listed as NCT03424460, this NA trial focuses on Myotonic Dystrophy 1 and remains completed. Sponsored by AFM-Téléthon (Funding), it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Oct 2025 — Present [monthly]
Completed NA
-
Oct 2024 — Oct 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2021 — Jul 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Feb 2021 — Dec 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Nov 2019 [monthly]
Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Feb 2019 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AFM-Téléthon (Funding)
- Assistance Publique - Hôpitaux de Paris
- Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
- URC-CIC Paris Descartes Necker Cochin
For direct contact, visit the study record on ClinicalTrials.gov .